Po‐Han Lin
Papers
1
Total Citations
4
H-Index
1
About
Dr. Po‑Han Lin is a leading urological oncologist whose research focuses on upper tract urothelial carcinoma (UTUC), a particularly aggressive cancer with high prevalence in Taiwan. His major contributions center on optimizing surgical management for UTUC, especially through segmental ureterectomy (SU) as a nephron‑sparing alternative to radical nephroureterectomy. Dr. Lin spearheaded a nationwide collaborative study across Taiwan—a UTUC endemic region—providing critical outcome data that had been previously absent. This landmark work, published in 2024 and already garnering 4 citations, demonstrates that SU offers comparable oncologic control for selected mid‑ and distal ureteral tumors while preserving renal function, directly informing clinical guidelines. By addressing the unique epidemiological challenges of UTUC in East Asia, Dr. Lin’s research bridges a significant gap in evidence‑based urology. His findings not only validate National Comprehensive Cancer Network recommendations but also establish a regional benchmark for treatment outcomes. Dr. Lin’s dedication to collaborative, high‑impact research continues to shape urological practice and improve patient care in endemic areas.
Research Focus
Key Achievements
Top Papers
- 1